Latest News

Welcome New Staff, Faculty, Fellows, Postgrads, Postdocs (September 2022)

Among patients who had catheter ablation for atrial fibrillation, women were more likely than men to require hospitalization for more than 1 day, to have major adverse events and to have poor quality of life outcomes, researchers reported.

In April 2022, the Department of Internal Medicine announced a grant funding opportunity for educational scholarship conducted by faculty in the department. The purpose of these grants is to help encourage and support scholarship and innovation in medical education.

The Heart Failure Society of America (HFSA) Annual Scientific Meeting will take place in Washington, D.C. from September 30, 2022 to October 3, 2022.

A Yale study found persistent racial and ethnic disparities in multimorbidity, which is defined as the presence of two or more concurrent chronic health conditions, in the United States over a 20-year period.

Safety and efficacy after using VASCADE closure device system was comparable with the standard treatment option for patients with severe peripheral artery disease.

Arya Mani, MD, FACC, FAHA, director of the Yale Medicine Cardiovascular Genetics Program, says certain cardiovascular diseases are significantly impacted by genes.

Shockwave Medical has announced a new clinical trial focused on the safety and effectiveness of its intravascular lithotripsy (IVL) technology in female patients.

September is peripheral artery disease (PAD) awareness month. Although scientists estimate that over 200 million people worldwide suffer from the condition, it’s often neglected in the cardiovascular space in favor of more well-studied diseases, Yale scientists say.